Verified ComparisonLast updated: 17 March 2026
Fragment 176-191 vs Liraglutide
Fragment 176-191 targets HGH-mediated lipid metabolism. Liraglutide is an approved GLP-1 agonist with broad metabolic effects.
HGH Fragment 176-191
Metabolic
3.5/ 5
B
Liraglutide
Metabolic
4.2/ 5
A−
Editor's note
Liraglutide is approved and established; Fragment 176-191 is lipid-specific.
| Criterion | HGH Fragment 176-191 | Liraglutide |
|---|---|---|
| Mechanism | HGH lipid fragment | GLP-1 agonism |
| Lipid preservation (selectivity) | High | Moderate |
| Regulatory status | Investigational | Approved |
| Weight-loss evidence | Limited | Extensive |
| Clinical adoption | None | Widespread |
Frequently asked questions
Fragment 176-191; Liraglutide for comprehensive weight loss.
Want to read the full reviews?